Annual Current Liabilities
$37.15 M
+$15.50 M+71.62%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual total current liabilities is $37.15 million, with the most recent change of +$15.50 million (+71.62%) on December 31, 2023.
- During the last 3 years, SPRO annual current liabilities has risen by +$22.81 million (+159.03%).
- SPRO annual current liabilities is now at all-time high.
Performance
SPRO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$49.10 M
+$3.46 M+7.59%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly total current liabilities is $49.10 million, with the most recent change of +$3.46 million (+7.59%) on September 30, 2024.
- Over the past year, SPRO quarterly current liabilities has increased by +$11.94 million (+32.15%).
- SPRO quarterly current liabilities is now -29.05% below its all-time high of $69.20 million, reached on March 31, 2022.
Performance
SPRO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SPRO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.6% | +32.1% |
| 3 y3 years | +159.0% | +32.1% |
| 5 y5 years | +201.6% | +32.1% |
SPRO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.0% | -29.1% | +245.0% |
| 5 y | 5-year | at high | +159.0% | -29.1% | +282.8% |
| alltime | all time | at high | +478.6% | -29.1% | +741.5% |
Spero Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.10 M(+7.6%) |
| Jun 2024 | - | $45.63 M(+9.1%) |
| Mar 2024 | - | $41.82 M(+12.6%) |
| Dec 2023 | $37.15 M(+71.6%) | $37.15 M(+45.9%) |
| Sep 2023 | - | $25.46 M(+47.0%) |
| Jun 2023 | - | $17.32 M(-24.6%) |
| Mar 2023 | - | $22.99 M(+6.2%) |
| Dec 2022 | $21.65 M(+16.0%) | $21.65 M(+33.4%) |
| Sep 2022 | - | $16.23 M(+14.0%) |
| Jun 2022 | - | $14.23 M(-79.4%) |
| Mar 2022 | - | $69.20 M(+270.6%) |
| Dec 2021 | $18.67 M(+30.2%) | $18.67 M(+8.2%) |
| Sep 2021 | - | $17.26 M(+34.6%) |
| Jun 2021 | - | $12.83 M(-27.8%) |
| Mar 2021 | - | $17.76 M(+23.8%) |
| Dec 2020 | $14.34 M | $14.34 M(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $17.56 M(-7.6%) |
| Jun 2020 | - | $19.01 M(-16.4%) |
| Mar 2020 | - | $22.74 M(-14.7%) |
| Dec 2019 | $26.66 M(+116.5%) | $26.66 M(+77.1%) |
| Sep 2019 | - | $15.06 M(+82.5%) |
| Jun 2019 | - | $8.25 M(+24.6%) |
| Mar 2019 | - | $6.62 M(-46.3%) |
| Dec 2018 | $12.32 M(+51.0%) | $12.32 M(+19.8%) |
| Sep 2018 | - | $10.28 M(+55.7%) |
| Jun 2018 | - | $6.60 M(+13.1%) |
| Mar 2018 | - | $5.83 M(-28.5%) |
| Dec 2017 | $8.16 M(+17.9%) | $8.16 M(+18.7%) |
| Sep 2017 | - | $6.87 M(+7.2%) |
| Jun 2017 | - | $6.41 M(-7.3%) |
| Dec 2016 | $6.92 M(+7.7%) | $6.92 M |
| Dec 2015 | $6.42 M | - |
FAQ
- What is Spero Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Spero Therapeutics?
- What is Spero Therapeutics annual current liabilities year-on-year change?
- What is Spero Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Spero Therapeutics?
- What is Spero Therapeutics quarterly current liabilities year-on-year change?
What is Spero Therapeutics annual total current liabilities?
The current annual current liabilities of SPRO is $37.15 M
What is the all time high annual current liabilities for Spero Therapeutics?
Spero Therapeutics all-time high annual total current liabilities is $37.15 M
What is Spero Therapeutics annual current liabilities year-on-year change?
Over the past year, SPRO annual total current liabilities has changed by +$15.50 M (+71.62%)
What is Spero Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SPRO is $49.10 M
What is the all time high quarterly current liabilities for Spero Therapeutics?
Spero Therapeutics all-time high quarterly total current liabilities is $69.20 M
What is Spero Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SPRO quarterly total current liabilities has changed by +$11.94 M (+32.15%)